Evidence map›Paper›PMID 38880601›Full record

ArticleThe American journal of pathology2024

Identification of HTRA4 as a Transcriptional Target of p63 in Trophoblast.

Mary E Donohoe, Robert Morey, Yingchun Li, Donald Pizzo, Sampada Kallol, Hee-Young Cho, Francesca Soncin, Mana M Parast

Abstract read
In one paragraph

Article in The American journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mary E DonohoeDepartment of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California.
Robert MoreyDepartment of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California.
Yingchun LiCenter for Genes, Environment, and Health, National Jewish Health, Denver, Colorado.
Donald PizzoDepartment of Pathology, University of California San Diego, La Jolla, California.
Sampada KallolDepartment of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California.
Hee-Young ChoDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Francesca SoncinDepartment of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California.
Mana M ParastDepartment of Pathology, University of California San Diego, La Jolla, California; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, California. Electronic address: mparast@health.ucsd.edu.

Funding

Cellular Atlas of the Human Placenta: Structure-Function Relationships and their Implications for Placental DysfunctionR01HD104805 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PARAST, MANA M · 2021 to 2025
$2.8M
Role of VGLL1 in human placental development and trophoblast specificationR01HD096260 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SONCIN, FRANCESCA · 2019 to 2023
$2.5M
NICHD NIH HHS R01 HD096260NICHD NIH HHS R01 HD104805
6 · The paper itself

Abstract

The placenta plays a crucial role in pregnancy success. ΔNp63α (p63), a transcription factor from the TP53 family, is highly expressed in villous cytotrophoblasts (CTBs), the epithelial stem cells of the human placenta, and is involved in CTB maintenance and differentiation. We examined the mechanisms of action of p63 by identifying its downstream targets. Gene expression changes were evaluated following overexpression and knockdown of p63 in the JEG3 choriocarcinoma cell line, using microarray-based RNA profiling. High-temperature requirement A4 (HTRA4), a placenta-specific serine protease involved in trophoblast differentiation and altered in preeclampsia, was identified as a gene reciprocally regulated by p63, and its expression was characterized in primary human placental tissues by RNA-sequencing and in situ hybridization. Potential p63 DNA-binding motifs were identified in the HTRA4 promoter, and p63 occupancy at some of these sites was confirmed using chromatin immunoprecipitation, followed by quantitative PCR in both JEG3 and trophoblast stem cells. These data begin to identify members of the transcriptional network downstream of p63, thus laying the groundwork for probing mechanisms by which this important transcription factor regulates trophoblast stemness and differentiation.

Indexed as

Transcription FactorsTrophoblastsCell DifferentiationCell Line, TumorFemaleHumansPlacentaPre-EclampsiaPregnancyPromoter Regions, GeneticSerine EndopeptidasesSerine ProteasesTranscription, GeneticTumor Suppressor ProteinsHtrA4 protein, humanSerine EndopeptidasesSerine ProteasesTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID38880601
PMCPMC11220921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.